COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,637 Articles (22,913 medRxiv, 8,724 bioRxiv)

Most recent first Previous |  Page 1563: Articles 15621-15630  | Next

COVID-19 Vaccine Intentions in the United States, December 2020 to March 2021
Czeisler, M. E., Rajaratnam, S. M. W., Howard, M. E., Czeisler, C. A.
10.1101/2021.05.16.21257290 — Posted: 2021-05-17
Monitoring of anti-SARS-CoV-2 IgG antibody immune response in infected and immunised healthcare workers in Hungary: a real-world longitudinal cohort study
Gervain, J., Szabo, K. B., Baki, E. H., Kadlecsik, L., Gyenesei, A., Herczeg, R., Simon, J.
10.1101/2021.05.16.21257288 — Posted: 2021-05-17
HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection
Augusto, D. G., Yusufali, T., Peyser, N. D., Butcher, X., Marcus, G. M., Olgin, J. E., Pletcher, M. J., Maiers, M., Hollenbach, J. A.
10.1101/2021.05.13.21257065 — Posted: 2021-05-17
Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells
Dinesh Kumar, N., Ter Ellen, B., Bouma, E. M., Troost, B., van de Pol, D. P. I., van der Ende-Metselaar, H. H., van Gosliga, D., Apperloo, L., Carpaij, O. A., van den Berge, M., Nawijn, M. C., Stienstra, Y., Rodenhuis-Zybert, I. A., Smit, J.
10.1101/2021.05.17.444467 — Posted: 2021-05-17
Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate
Su, D., Li, X., He, C., Huang, X., Chen, M., Wang, Q., Qin, W., Liang, Y., Xu, R., Wu, J., Luo, P., Yang, X., Zeng, Y., Luo, M., Luo, D., Salisbury, D. M., Ambrosino, D., Siber, G., Clemens, R., Liang, P., Liang, J. G.
10.1101/2021.05.16.444369 — Posted: 2021-05-17
Factors Associated with the Acceptance and Willingness of COVID-19 Vaccination among Chinese Healthcare Workers
Ye, X., Ye, W., Yu, J., Gao, Y., Ren, Z., Chen, L., Dong, A., Yi, Q., Zhan, C., Lin, Y., Wang, Y., Huang, S., Song, P.
10.1101/2021.05.15.21257094 — Posted: 2021-05-17
Pre-Exposure Prophylaxis with Various Doses of Hdroxychloroquine among high-risk COVID 19 Healthcare Personnel: CHEER randomized controlled trial
Syed, F., Arif, M. A., Niazi, R., Baqar, J. B., Hashmi, U. L., Batool, S., Ashraf, S., Arshad, J., Musarrat, S.
10.1101/2021.05.17.21257012 — Posted: 2021-05-17
Sociodemographic inequality in COVID-19 vaccination coverage amongst elderly adults in England: a national linked data study
Nafilyan, V., Dolby, T., Razieh, C., Gaughan, C., Morgan, J., Ayoubkhani, D., Walker, A. S., Khunti, K., Glickman, M., Yates, T.
10.1101/2021.05.13.21257146 — Posted: 2021-05-17
Serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from a prospective community cohort study (Virus Watch).
Geismar, C. R., Fragaszy, E., Nguyen, V. G., Fong, W. L. E., Shrotri, M., Beale, S., Rodger, A., Lampos, V., Byrne, T. E., Kovar, J., Navaratnam, A., Patel, P., Aldridge, R. W., Hayward, A., Virus Watch Collaborative
10.1101/2021.05.17.21257223 — Posted: 2021-05-17
The SARS-CoV-2 B.1.351/V2 variant is outgrowing the B.1.1.7/V1 variant in French regions in April 2021
Roquebert, B., Trombert-Paolantoni, S., Haim-Boukobza, S., Lecorche, E., Verdurme, L., Foulonge, V., Sofonea, M. T., Alizon, S.
10.1101/2021.05.12.21257130 — Posted: 2021-05-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).